Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 84,865,992
  • Shares Outstanding, K 1,265,146
  • Annual Sales, $ 22,127 M
  • Annual Income, $ 5,455 M
  • 60-Month Beta 1.14
  • Price/Sales 3.77
  • Price/Cash Flow 9.00
  • Price/Book 4.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.57
  • Number of Estimates 8
  • High Estimate 1.64
  • Low Estimate 1.41
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +17.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.38 +7.53%
on 11/14/19
67.65 -0.84%
on 11/26/19
+1.67 (+2.55%)
since 11/06/19
3-Month
60.89 +10.17%
on 10/03/19
68.16 -1.58%
on 09/11/19
+2.26 (+3.49%)
since 09/06/19
52-Week
60.32 +11.21%
on 12/26/18
70.50 -4.85%
on 02/01/19
-3.11 (-4.43%)
since 12/06/18

Most Recent Stories

More News
Kite Announces Long-term Data From ZUMA-1 Showing Approximately Half of Refractory Large B-cell Lymphoma Patients Were Alive Three Years After Yescarta Treatment

-- Separate Cohort Finds Earlier Steroid Use May Reduce Risk of Severe Cytokine Release Syndrome and Neurologic Events --

GILD : 67.08 (+1.74%)
Glaxo Files NDA for Fostemsavir for Heavily Pre-Treated HIV

Glaxo (GSK) submits a new drug application to the FDA for its first-in-class attachment inhibitor fostemsavir, which is being evaluated for the treatment of HIV-1 infection.

GSK : 45.51 (+0.66%)
PFE : 38.29 (+0.68%)
JNJ : 140.38 (+0.59%)
GILD : 67.08 (+1.74%)
Gilead Sciences COMPASS Initiative(TM) Awards Over $2.3M to 40 Organizations Fighting HIV in the South

Today, Emory University Rollins School of Public Health, Southern AIDS Coalition, and the University of Houston Graduate College of Social Work announced 40 organizations that will receive a total of $2,309,592...

GILD : 67.08 (+1.74%)
Health program offers free HIV prevention drug to uninsured

WASHINGTON (AP) — The government launched a new program on Tuesday to provide an HIV prevention drug for free to people who need the protection but have no insurance to pay for it.

GILD : 67.08 (+1.74%)
Intercept (ICPT) Gains 7.5% YTD on Progress in NASH Space

Intercept (ICPT) stock gains as it becomes the forerunner in the NASH drug race.

NVS : 92.07 (+0.47%)
CNAT : 0.37 (-1.86%)
ICPT : 107.48 (-10.27%)
GILD : 67.08 (+1.74%)
National AIDS Memorial Welcomes First Panels of the AIDS Quilt Home to San Francisco During World AIDS Day Observances; Honors Leaders in the HIV-AIDS Movement

This World AIDS Day, more than 1,500 people are expected to gather in the heart of the National AIDS Memorial to welcome home the first group of panels of the AIDS Memorial Quilt (the Quilt) back to San...

GILD : 67.08 (+1.74%)
DGX : 106.92 (+0.73%)
WFC : 54.37 (+2.14%)
National AIDS Memorial Receives $2.4 Million Donation From Gilead Sciences to Support the AIDS Memorial Quilt as It Moves Home to San Francisco

Today, the National AIDS Memorial and Gilead Sciences, Inc. (Nasdaq: GILD) announced a $2.4 million donation from Gilead to support The AIDS Memorial Quilt (The Quilt), its public education programs and...

GILD : 67.08 (+1.74%)
AID FOR AIDS RAISES $1.3 MILLION DOLLARS AT ITS 2019 MY HERO GALA

AID FOR AIDS International, Inc. raised over 1.3 million dollars at its signature My Hero Gala on Monday, November 25th. Held at the American Museum of Natural History, this year's gala focused on Venezuela...

GILD : 67.08 (+1.74%)
Intercept's (ICPT) NDA for NASH Drug Gets Priority Review

Intercept (ICPT) obtains Priority Review for its NDA for OCA in the United States for the treatment of fibrosis due to NASH.

ICPT : 107.48 (-10.27%)
GILD : 67.08 (+1.74%)
ALKS : 20.95 (+1.45%)
CBAY : 1.75 (+5.42%)
Gilead Sciences Set to Possibly Pullback After Yesterday's Rally of 1.56%

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $65.49 to a high of $66.38. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

GILD : 67.08 (+1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade GILD with:

Business Summary

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products...

See More

Key Turning Points

2nd Resistance Point 68.37
1st Resistance Point 67.72
Last Price 67.08
1st Support Level 66.26
2nd Support Level 65.44

See More

52-Week High 70.50
Last Price 67.08
Fibonacci 61.8% 66.61
Fibonacci 50% 65.41
Fibonacci 38.2% 64.21
52-Week Low 60.32

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar